Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat.
about
Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonistsCharacterization and regulation of tachykinin receptors in the nucleus tractus solitarius.Intracerebroventricular responses to neuropeptide gamma in the conscious rat: characterization of its receptor with selective antagonists.Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: Evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene.Behavioral effects of local microinfusion of pituitary adenylate cyclase activating polypeptide (PACAP) into the paraventricular nucleus of the hypothalamus (PVN).The role of neuropeptides in adverse myocardial remodeling and heart failure.Hypothalamic tachykinins. Mediators of stress responses?Central tachykinins: mediators of defence reaction and stress reactions.Substance P receptor antagonism: a potential novel treatment option for viral-myocarditisCharacterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat.Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.Cardiovascular and behavioural effects of centrally administered neuropeptide K in the rat: receptor characterization.Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.Respiratory action of capsaicin microinjected into the nucleus of the solitary tract: involvement of vanilloid and tachykinin receptors.The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.Presence of NK2 binding sites in the rat brain.
P2860
Q24679394-A6F1F22B-53BE-4574-99F5-F54CA9D5752DQ34079168-F6B83BE9-4527-4B62-857F-86EE73954AF8Q35873258-17E731F3-1DAF-4447-A8A8-57663A2A5351Q35944951-BDE0242D-143D-480B-BA36-F478D5D7D4E5Q35944956-C22FEF52-28CB-4571-B03D-F8F1F0000A82Q39093111-928D3C36-BDC2-47E1-92EC-9B64318ABAE0Q40967762-191B0B4A-2176-4F83-92E6-81363EEA3CA8Q41143422-2AAB5ED4-72CB-4FDA-BB38-158958A27A78Q41371705-41D76718-40A8-426D-BAD9-E1752348DB3BQ41821983-7EE4DA7F-B548-4AB9-98E7-5A38A74653A2Q41872098-67DCB8FE-AE9B-4C41-A646-8EC5E16F5926Q42097975-9D4B1B70-F7E2-4462-9C1A-C626D917024BQ42370128-8F85862A-8F67-4A47-816A-C1DE53D7EDB6Q43142996-441FDE11-D75C-450D-938B-224D23BEEB38Q43261429-06F50E85-AA16-4C2B-B6E1-3CB3C56EBBD2Q43820022-C2BBE52E-D430-4462-93AC-A73945C60FB5
P2860
Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Use of selective antagonists t ...... and NK2 receptors in the rat.
@en
Use of selective antagonists t ...... and NK2 receptors in the rat.
@nl
type
label
Use of selective antagonists t ...... and NK2 receptors in the rat.
@en
Use of selective antagonists t ...... and NK2 receptors in the rat.
@nl
prefLabel
Use of selective antagonists t ...... and NK2 receptors in the rat.
@en
Use of selective antagonists t ...... and NK2 receptors in the rat.
@nl
P2093
P2860
P1476
Use of selective antagonists t ...... and NK2 receptors in the rat.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1992.TB14518.X
P407
P50
P577
1992-11-01T00:00:00Z